EMIT-TOX SERUM TRICYCLIC ANTIDEPR. ASSAY
K-Number: K821743 · 1982-07-02
Advertisement
Device Summary
Frequently Asked Questions
What is the EMIT-TOX SERUM TRICYCLIC ANTIDEPR. ASSAY?
EMIT-TOX SERUM TRICYCLIC ANTIDEPR. ASSAY is a medical device that received FDA 510(k) clearance on 1982-07-02. The listed applicant is Syva Co.. The 510(k) number is K821743.
When did EMIT-TOX SERUM TRICYCLIC ANTIDEPR. ASSAY receive FDA 510(k) clearance?
EMIT-TOX SERUM TRICYCLIC ANTIDEPR. ASSAY received FDA 510(k) clearance on 1982-07-02, under 510(k) number K821743.
Who is the listed applicant for EMIT-TOX SERUM TRICYCLIC ANTIDEPR. ASSAY?
The FDA 510(k) record lists Syva Co. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for EMIT-TOX SERUM TRICYCLIC ANTIDEPR. ASSAY?
The FDA product code for EMIT-TOX SERUM TRICYCLIC ANTIDEPR. ASSAY is LFG.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing Syva Co. as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: LFG)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.
Advertisement